Majority Of Biopharma Firms In China Enjoy Net Profit Growth In 2010
This article was originally published in PharmAsia News
Roughly 61 of the 87 Chinese pharmaceutical companies disclosed their performance forecasts for 2010 with an estimated growth of 25 to 30 percent on average in net profits, and 43 companies predicted an increase of over 30 percent, according to financial analysis company Wind's statistics Jan. 30
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.